China Money Network
Login
Join

Chinese Biotech Firm Magpie Pharmaceuticals Raises Nearly $15M In Series B Round

  • February 13, 2019 — 11:42 CST

This Data Is Locked!

This area is available only to Subscribers.

Guangzhou-based biotechnology company Magpie Pharmaceuticals announced on Monday that it has raised a nearly RMB100 million (US$14.8 million) series B financing round from Chinese venture... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: